These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 173609

  • 1. The control of insulin receptors in the New Zealand obese mouse.
    Baxter D, Lazarus NR.
    Diabetologia; 1975 Aug; 11(4):261-7. PubMed ID: 173609
    [Abstract] [Full Text] [Related]

  • 2. Decreased binding of insulin to liver plasma membrane receptors in hereditary diabetic mice.
    Kern P, Picard J, Caron M, Veissière D.
    Biochim Biophys Acta; 1975 May 06; 389(2):281-9. PubMed ID: 166675
    [Abstract] [Full Text] [Related]

  • 3. Insulin receptors in the heart muscle. Demonstration of specific binding sites and impairment of insulin binding in the plasma membrane of the obese hyperglycemic mouse.
    Forgue ME, Freychet P.
    Diabetes; 1975 Aug 06; 24(8):715-23. PubMed ID: 169173
    [Abstract] [Full Text] [Related]

  • 4. Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)?
    Chankiewitz E, Peschke D, Herberg L, Bazwinsky I, Mühlbauer E, Brömme HJ, Peschke E.
    Exp Clin Endocrinol Diabetes; 2006 May 06; 114(5):262-9. PubMed ID: 16804801
    [Abstract] [Full Text] [Related]

  • 5. Studies on implanted islets of Langerhans: normalization of blood glucose concentration, blood insulin concentration and weight gain in New Zealand obese mice.
    Gates RJ, Hunt MI, Smith R, Lazarus NR.
    Biochem J; 1972 Nov 06; 130(1):26P-27P. PubMed ID: 4632170
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The ability of pancreatic polypeptides (APP and BPP) to return to normal the hyperglycaemia, hyperinsulinaemia and weight gain of New Zealand obese mice.
    Gates RJ, Lazarus NR.
    Horm Res; 1977 Nov 06; 8(4):189-202. PubMed ID: 411725
    [Abstract] [Full Text] [Related]

  • 8. The effect of oxytetracycline on insulin resistance in obese mice.
    Bégin-Heck N, Bourassa M, Heick HM.
    Biochem J; 1974 Sep 06; 142(3):465-75. PubMed ID: 4464837
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glucose utilization in relation to insulin secretion in NZO and C57Bl mouse islets.
    Larkins RG, Simeonova L, Veroni MC.
    Endocrinology; 1980 Nov 06; 107(5):1634-8. PubMed ID: 6159204
    [Abstract] [Full Text] [Related]

  • 11. Estradiol (E2) Improves Glucose-Stimulated Insulin Secretion and Stabilizes GDM Progression in a Prediabetic Mouse Model.
    Liebmann M, Asuaje Pfeifer M, Grupe K, Scherneck S.
    Int J Mol Sci; 2022 Jun 15; 23(12):. PubMed ID: 35743136
    [Abstract] [Full Text] [Related]

  • 12. Insulin binding to liver plasm membranes in the obese hyperglycemic (ob/ob) mouse. Demonstration of a decreased number of functionally normal receptors.
    Soll AH, Kahn CR, Neville DM.
    J Biol Chem; 1975 Jun 25; 250(12):4702-7. PubMed ID: 167002
    [Abstract] [Full Text] [Related]

  • 13. Immune abnormalities in the diabetic New Zealand obese (NZO) mouse: insulin treatment partially suppresses splenic hyperactivity measured by flow cytometric analysis.
    Melez KA, Attallah AM, Harrison ET, Raveche ES.
    Clin Immunol Immunopathol; 1985 Jul 25; 36(1):110-9. PubMed ID: 3891173
    [Abstract] [Full Text] [Related]

  • 14. The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function.
    Radavelli-Bagatini S, Blair AR, Proietto J, Spritzer PM, Andrikopoulos S.
    J Endocrinol; 2011 Jun 25; 209(3):307-15. PubMed ID: 21429962
    [Abstract] [Full Text] [Related]

  • 15. Effect of islet activating protein on glucose tolerance, insulin secretion and insulin responsiveness in the NZO mouse.
    Re CA, Veroni MC, Larkins RG.
    Diabetologia; 1984 Apr 25; 26(4):304-9. PubMed ID: 6376239
    [Abstract] [Full Text] [Related]

  • 16. Impaired insulin action in adipocytes of New Zealand obese mice: a role for postbinding defects in pyruvate dehydrogenase and insulin mediator activity.
    Macaulay SL, Larkins RG.
    Metabolism; 1988 Oct 25; 37(10):958-65. PubMed ID: 3050367
    [Abstract] [Full Text] [Related]

  • 17. Obese mice have higher insulin receptor levels in the hepatocyte cell nucleus following insulin stimulation in vivo with an oral glucose meal.
    Gletsu NA, Field CJ, Clandinin MT.
    Biochim Biophys Acta; 1999 Aug 30; 1454(3):251-60. PubMed ID: 10452959
    [Abstract] [Full Text] [Related]

  • 18. Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese mice.
    Kluge R, Giesen K, Bahrenberg G, Plum L, Ortlepp JR, Joost HG.
    Diabetologia; 2000 Dec 30; 43(12):1565-72. PubMed ID: 11151768
    [Abstract] [Full Text] [Related]

  • 19. Reduced insulin binding to liver plasma membranes in inherently obese diabetic CBA/Ca mice.
    Taberner PV, Connelly DM.
    Biochem Pharmacol; 1991 Mar 01; 41(5):729-33. PubMed ID: 1998527
    [Abstract] [Full Text] [Related]

  • 20. Role of Serotonin (5-HT) in GDM Prediction Considering Islet and Liver Interplay in Prediabetic Mice during Gestation.
    Asuaje Pfeifer M, Liebmann M, Beuerle T, Grupe K, Scherneck S.
    Int J Mol Sci; 2022 Jun 09; 23(12):. PubMed ID: 35742878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.